Lung Cancer & COVID Infection
Trial Objectives
Researchers want to understand how the body of a person with active lung cancer responds to COVID-19, should they contract the virus. Volunteers do not need to be vaccinated or to have an active case of COVID to participate. Study participants will be required to provide a blood sample and their medical history.
Who Can Participate
Adults with an active diagnosis of lung cancer.
Age: 18+ Gender: Any
Estimated Time Commitment
Up to 24 months. In-person study visits occurring at enrollment and at these monthly intervals- 3, 6, 9, 12, 15, 18, 21 and 24 months.
Payment & Reimbursement
Payment: Not Provided
Travel Reimbursement: Not Available
Trial Contact
For more information, contact:
Jennifer Underwood
303.398.1518
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
National Cancer Institute
Principal Investigators
Jeffrey Kern, MD
Co-Investigators
Laurie L. Carr, MD